Mupirocin and Elmiron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mupirocin (mupirocin) and Elmiron (pentosan polysulfate sodium). Common drug interactions include arthralgia among females and macular scar among males.

The phase IV clinical study analyzes what interactions people have when they take Mupirocin and Elmiron. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Elmiron?

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). eHealthMe is studying from 10,215 Elmiron users. Check the latest studies of Elmiron.



On Jul, 18, 2026

21 people who take Mupirocin and Elmiron together, and have interactions are studied.

Mupirocin and Elmiron drug interactions.

What are the common drug interactions of Mupirocin and Elmiron, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Heart rate increased
  3. Age-related macular degeneration
  4. Anxiety
  5. Back disorder
  6. Blood pressure decreased
  7. Drug ineffective
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Heart rate decreased

male:

  1. Macular scar
  2. Retinal degeneration (death of the cells of the retina)
  3. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  4. Age-related macular degeneration
  5. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)

What are the common drug interactions of Mupirocin and Elmiron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Diarrhoea
  5. Emotional distress
  6. Pain
  7. Vomiting

30-39:

  1. Abdominal discomfort
  2. Arthralgia (joint pain)
  3. Back disorder
  4. Blood pressure decreased
  5. Drug ineffective
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Headache (pain in head)
  9. Heart rate decreased
  10. Heart rate increased

40-49:

  1. Age-related macular degeneration
  2. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  3. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  4. Migraine (headache)
  5. Retinal dystrophy (progressive weakness and wasting of the retina)
  6. Retinal injury (injury to retina)
  7. Retinal toxicity (retina damage due to medication)

50-59:

  1. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  2. Anxiety
  3. Blindness
  4. Depression
  5. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  6. Retinal pigmentation (pigmentation of retina)

60+:

  1. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  2. Age-related macular degeneration
  3. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  4. Femur fracture
  5. Pain in extremity
  6. Spinal disorder (disease of spine a back bone)
  7. Uterine disorder
  8. Macular scar
  9. Retinal degeneration (death of the cells of the retina)
  10. Astigmatism (refractive error of the eye in which parallel rays of light from an external source do not converge on a single focal point on the retina)

What are the existing conditions these people have? *

  1. Cystitis Interstitial (unknown cause characterized by bladder pain): 15 people, 71.43%
  2. Pain: 9 people, 42.86%
  3. Multiple Allergies (allergy to multiple agents): 8 people, 38.10%
  4. Infection: 8 people, 38.10%
  5. Nausea (feeling of having an urge to vomit): 8 people, 38.10%
  6. High Blood Cholesterol: 8 people, 38.10%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 33.33%
  8. Stress And Anxiety: 7 people, 33.33%
  9. High Blood Pressure: 6 people, 28.57%
  10. Depression: 6 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and Elmiron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mupirocin and Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elmiron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin and pentosan polysulfate sodium (the active ingredients of Mupirocin and Elmiron, respectively), and Mupirocin and Elmiron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: